2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
D

2020 ASCO Updates for High-Risk SCCHN: Is Post-Operative Weekly Cisplatin 40mg/m2 Inferior to Bolus Cisplatin With RT?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Deborah Wong
By 2020 ASCO Virtual Direct™ Highlights FEATURING Deborah Wong
31 views
September 29, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

06:40
Lilly Medical Affairs

Communicating the Risk of Recurrence for Patients With HR+, HER2- Ea…

Feat. J. O’Shaughnessy

Featured Video

03:57
Lilly Medical Affairs

Resistance Mechanisms to ET, Including ESR1 Mutations in HR+, HER2- …

Feat. K. Jhaveri
Head&Neck
10:06

2020 ASCO Updates on HPV+ Oropharynx Cancer: Can TORS and Reduced Do…

2020 ASCO Virtual Direct™ Highlights

D. Wong

11 views
13:56

2020 ASCO Updates for High-Risk SCCHN: Is Post-Operative Weekly Cisp…

2020 ASCO Virtual Direct™ Highlights

D. Wong

31 views
17:05

2020 ASCO Highlights on Solid H&N Tumors With HRAS Mutations: Is Tip…

2020 ASCO Virtual Direct™ Highlights

D. Wong

20 views